The global increase in diabetes mellitus is leading to a parallel increase in the incidence of cardiovascular complications, which remain the leading cause of death in this patient group. In recent years, the discovery of ferroptosis, an iron-dependent and non-apoptotic form of programmed cell death, has provided new insights into the pathophysiology of diabetes-associated heart disease. This review article deepens the understanding of the molecular mechanisms underlying ferroptosis in the cardiovascular system in diabetes and highlights innovative pharmacological and experimental therapeutic approaches that target ferroptosis pathways.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Type 2 diabetes: sarcopenia and frailty
How can the breakdown of skeletal muscles be stopped?
- Cholangiocarcinoma
Modern molecular diagnostics and targeted therapy options
- Treatment resistant depression
Esketamine nasal spray as monotherapy? New for treatment-resistant depression
- Analysis of SNVCS data from the period 2005-2022
TBE vaccination for children and adolescents in Switzerland
- Tuberculosis
Detecting diabetes in TB patients early and efficiently
- Trichophyton indotineae
Terbinafine-resistant dermatophytoses are on the rise in Central Europe
- Peristomal skin health
Focus on preventive care options
- Disease-modifying therapies for ATTR-CM